Human Stem Cells Institute PJSC Logo

Human Stem Cells Institute PJSC

ISKJ | MOEX

Overview

Corporate Details

ISIN(s):
RU000A0JNAB6
LEI:
Country:
Russian Federation
Address:
3 Gubkina Street PO Box 373, 119333  Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Artgen Biotech PJSC (formerly Human Stem Cells Institute PJSC) is a biotechnology company focused on developing and commercializing innovative platform technologies for the healthcare industry. Operating as a strategic investor, it manages a portfolio of biotech companies at various stages of development, fostering an ecosystem for research and commercialization. The company's core activities center on drug discovery, R&D, and marketing of proprietary products and services in regenerative medicine, gene therapy, and cell-based technologies. Key offerings include biomedical drugs (vaccines, gene therapies), medical devices based on gene-activated materials, and medical services such as biobanking (cord blood stem cells) and genetic research.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Human Stem Cells Institute PJSC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Human Stem Cells Institute PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Human Stem Cells Institute PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN